Eric A. Dietrich, PharmD, BCPS

coumadin
coumadin
Telephone-Based INR Management
01/22/2015
Eric A. Dietrich, PharmD, BCPS
Home monitoring of blood pressure and blood glucose have become mainstays in the treatment of hypertension and diabetes, allowing patients to take an active role in their disease management.
01/22/2015
Osteoarthritis
Osteoarthritis
The Potential Risks and Benefits Associated With the Use of Celecoxib and Other NSAIDs
02/07/2017
Eric A. Dietrich, PharmD, BCPS; Kyle Davis, PharmD, BCPS
Nonsteroidal anti-inflammatory drugs (NSAIDs) are used for the treatment of mild to moderate pain.
02/07/2017
Atrial Fibrillation
Atrial Fibrillation
Warfarin and Atrial Fibrillation
02/20/2014
Louis Kuritzky, MD; Eric A. Dietrich, PharmD, BCPS
The advent of a variety of methodologically new antithrombotic agents has provided clinicians with important choices to make when selecting treatments for commonplace syndromes, such as atrial...
02/20/2014
Controversies in Clinical Care
Controversies in Clinical Care
Is Cross-Reactivity of Concern With Sulfa-Containing Medications?
01/21/2016
Eric A. Dietrich, PharmD, BCPS; Kyle Davis, PharmD, BCPS
Allergies to sulfa-containing drugs are common and lead to significant concern regarding alternative medications as well as cross-reactivity.
01/21/2016
Controversies in Clinical Care
Controversies in Clinical Care
Is Aspirin an Alternative Therapy for Venous Thromboembolism Prevention?
12/18/2019
Eric A. Dietrich, PharmD, BCPS; Kyle Davis, PharmD, BCPS
The management of venous thromboembolism has dramatically changed over the past 5 to 10 years. With the advent of direct-acting oral...
12/18/2019
Anticoagulant
Anticoagulant
How to Talk to Patients About the Novel Oral Anticoagulants
12/12/2014
Eric A. Dietrich, PharmD, BCPS
Over the past couple of years 3 novel oral anticoagulants (NOACs) have been FDA approved: dabigatran (Pradaxa, Boehringer Ingelheim), rivaroxaban (Xarelto, Janssen), and apixaban. Originally approved for...
12/12/2014
Controversies in Clinical Care
Controversies in Clinical Care
Choosing an SGLT-2 Inhibitor for a Patient With Type 2 Diabetes: Which Agent (if Any) Is Best?
10/31/2016
Eric A. Dietrich, PharmD, BCPS; Kyle Davis, PharmD, BCPS
Three SGLT-2 inhibitors are available in the United States: canagliflozin, dapagliflozin, and empagliflozin. All 3 are brand-name, are administered orally once daily, and lead to similar hemoglobin A1c...
10/31/2016
Corticosteroid
Corticosteroid
Corticosteroids in the Setting of Community-Acquired Pneumonia
12/15/2015
Eric A. Dietrich, PharmD, BCPS; Kyle Davis, PharmD, BCPS
Systemic corticosteroids are commonly prescribed to treat acute exacerbations of respiratory diseases, such as asthma and chronic obstructive pulmonary disease.
12/15/2015
Controversies in Clinical Care
Controversies in Clinical Care
Antibiotics for Acute Bacterial Prostatitis: Which Agent, and for How Long?
10/01/2019
Eric A. Dietrich, PharmD, BCPS; Kyle Davis, PharmD, BCPS
JH is a 67-year-old man with a history of hypertension and depression who presents dysuria, increased urinary frequency, and suprapubic pain.
10/01/2019
Diabetes Q&A
Diabetes Q&A
When Can Intervals Between INR Checks Be Extended?
11/18/2014
Eric A. Dietrich, PharmD, BCPS
The CHEST guidelines recommend monitoring the INR every 4 weeks in most patients. However, in those patients who have been stable on warfarin therapy for at least 3 months, CHEST suggests that it is...
11/18/2014